CNMD
Conmed Corp.

209
Mkt Cap
$1.45B
Volume
247,867.00
52W High
$76.43
52W Low
$40.16
PE Ratio
21.25
CNMD Fundamentals
Price
$43.42
Prev Close
$43.76
Open
$43.76
50D MA
$45.48
Beta
0.99
Avg. Volume
350,095.30
EPS (Annual)
$4.25
P/B
1.34
Rev/Employee
$334,033.33
Loading...
Loading...
News
all
press releases
Why Conmed (CNMD) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks·1d ago
News Placeholder
More News
News Placeholder
Insider Selling: CONMED (NYSE:CNMD) Insider Sells $10,590.97 in Stock
CONMED Corporation (NYSE:CNMD - Get Free Report) insider Richard Glaze sold 257 shares of the stock in a transaction on Friday, November 21st. The stock was sold at an average price of $41.21, for a...
MarketBeat·3d ago
News Placeholder
CNMD vs. MMSI: Which Stock Is the Better Value Option?
CNMD vs. MMSI: Which Stock Is the Better Value Option?
Zacks·4d ago
News Placeholder
Why Conmed (CNMD) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks·4d ago
News Placeholder
Down 16.9% in 4 Weeks, Here's Why Conmed (CNMD) Looks Ripe for a Turnaround
The heavy selling pressure might have exhausted for Conmed (CNMD) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Zacks·8d ago
News Placeholder
CONMED Corporation (NYSE:CNMD) Given Average Recommendation of "Hold" by Brokerages
CONMED Corporation (NYSE:CNMD - Get Free Report) has been assigned a consensus recommendation of "Hold" from the six ratings firms that are currently covering the stock, MarketBeat Ratings reports...
MarketBeat·11d ago
News Placeholder
CONMED (NYSE:CNMD) Sets New 12-Month Low - What's Next?
CONMED (NYSE:CNMD) Hits New 12-Month Low - What's Next...
MarketBeat·13d ago
News Placeholder
Is CONMED (CNMD) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks·15d ago
News Placeholder
Conmed (CNMD) is a Top-Ranked Growth Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks·17d ago
News Placeholder
Wall Street Analysts Think Conmed (CNMD) Could Surge 25.54%: Read This Before Placing a Bet
The average of price targets set by Wall Street analysts indicates a potential upside of 25.5% in Conmed (CNMD). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks·18d ago

Latest CNMD News

View

Advertisement|Remove ads.

Advertisement|Remove ads.